Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.34 Insider Own3.60% Shs Outstand65.73M Perf Week4.65%
Market Cap533.07M Forward P/E- EPS next Y-0.05 Insider Trans8.78% Shs Float57.88M Perf Month16.69%
Income-84.30M PEG- EPS next Q-0.17 Inst Own66.30% Short Float25.92% Perf Quarter3.31%
Sales157.30M P/S3.39 EPS this Y-169.90% Inst Trans-0.55% Short Ratio14.34 Perf Half Y-8.36%
Book/sh4.19 P/B1.94 EPS next Y93.20% ROA-19.10% Target Price11.38 Perf Year1.88%
Cash/sh2.05 P/C3.95 EPS next 5Y- ROE-31.80% 52W Range6.36 - 10.32 Perf YTD-8.36%
Dividend- P/FCF- EPS past 5Y-18.30% ROI-17.20% 52W High-21.41% Beta1.90
Dividend %- Quick Ratio2.60 Sales past 5Y40.30% Gross Margin82.10% 52W Low27.52% ATR0.29
Employees226 Current Ratio2.70 Sales Q/Q3.60% Oper. Margin-35.00% RSI (14)58.00 Volatility4.50% 3.85%
OptionableYes Debt/Eq0.35 EPS Q/Q-388.90% Profit Margin-57.10% Rel Volume0.54 Prev Close8.15
ShortableYes LT Debt/Eq0.35 EarningsAug 07 AMC Payout- Avg Volume1.05M Price8.11
Recom2.40 SMA206.15% SMA504.46% SMA200-0.52% Volume571,700 Change-0.49%
15-Jul-14Upgrade R. F. Lafferty Sell → Neutral $7.50
07-Oct-13Initiated HC Wainwright Buy $15
29-May-13Initiated Burrill Institutional Research Mkt Outperform $12
13-Mar-13Reiterated RBC Capital Mkts Outperform $19 → $16
13-Mar-13Downgrade WallachBeth Buy → Sell $20 → $5.50
02-May-11Reiterated MLV Capital Buy $12.50 → $20.50
25-Mar-11Initiated RBC Capital Mkts Outperform $12
07-Dec-10Reiterated Morgan Joseph Buy $8 → $10
12-Jan-10Upgrade Morgan Joseph Hold → Buy $8
14-Oct-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
08-Sep-09Downgrade Morgan Joseph Buy → Hold
09-Sep-08Initiated Morgan Joseph Buy $5
23-Apr-08Downgrade Oppenheimer Outperform → Perform
18-Mar-08Downgrade Brean Murray Buy → Hold
01-Nov-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
31-Oct-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
09-Oct-07Upgrade Brean Murray Hold → Buy $11
25-Jul-07Upgrade Brean Murray Sell → Hold
25-Jul-07Reiterated Lazard Capital Buy $11 → $6
25-Jul-07Downgrade Friedman Billings Outperform → Mkt Perform $12.25 → $5.50
18-Aug-14 07:47AM  Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval at TheStreet
15-Aug-14 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials EDGAR Online Financials
12-Aug-14 10:30AM  Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 Zacks
08-Aug-14 05:12PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online +5.94%
09:31AM  H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals Benzinga
07-Aug-14 04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:21PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:18PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:00PM  Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second Quarter, Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster Business Wire
07:35AM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
07:07AM  Q2 2014 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
05-Aug-14 01:48PM  These eight health-care stocks could rise up to 75% at MarketWatch
31-Jul-14 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2014 Financial Results Teleconference and Webcast Business Wire
15-Jul-14 10:22AM  Spectrum Pharma upgraded by R. F. Lafferty Briefing.com
09-Jul-14 04:31PM  Spectrum Pharmaceuticals: Key Drug Fusilev May Face Generic Competition Soon at Seeking Alpha
07-Jul-14 05:01PM  A Bad Day for Spectrum Pharmaceuticals' Good News at Motley Fool
03:00PM  Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq Zacks
10:58AM  Spectrum receives accelerated FDA approval for Beleodaq at theflyonthewall.com
10:17AM  Why Spectrum Pharmaceuticals (SPPI) Stock Is Higher This Morning at TheStreet
09:04AM  Mondays Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance at Motley Fool
07:11AM  Spectrum Pharmaceuticals granted accelerated approval of lymphoma treatment at MarketWatch
07:00AM  FDA Grants Spectrum Pharmaceuticals Accelerated Approval of Beleodaq (belinostat) for Injection Business Wire
06-Jul-14 12:32PM  This Week in Biotech: Allergan Three-Peat's in a Bad Way While Agenus Impresses at Motley Fool
03-Jul-14 01:48PM  FDA approves lymphoma drug from Spectrum Pharma AP
01:14PM  Spectrum Pharma Lymphoma Drug Approved Early at Investor's Business Daily
12:59PM  FDA approves lymphoma drug from Spectrum Pharma AP
11:58AM  Midday movers: Lorillard, PetSmart, Walgreen & More at CNBC
11:46AM  Spectrum Pharmaceuticals Shares Up 5% Following FDA Accelerated Approval For Beleodaq (SPPI) Benzinga
11:42AM  FDA approves lymphoma drug from Spectrum Pharma AP
11:19AM  FDA approves Spectrum Pharma's blood cancer drug Reuters
10:51AM  Spectrum confirms FDA approves Beleodaq, updates on PMRs for Beleodaq, Folotyn theflyonthewall.com
10:31AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Triggering Events That Accelerate or Incre EDGAR Online
27-Jun-14 05:33PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
05:33PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
05:01PM  3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir at Motley Fool
05:01PM  3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir
26-Jun-14 04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online
04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
30-May-14 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd Business Wire
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd
28-May-14 07:15AM  Spectrum completes enrollment in SPI-2012 Phase 2 Trial at theflyonthewall.com
07:15AM  Spectrum completes enrollment in SPI-2012 Phase 2 Trial
07:00AM  Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 - A Novel Long-Acting Granulocyte Colony Stimulating Factor (GCSF) to Treat Chemotherapy-induced Neutropenia Business Wire
07:00AM  Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 - A Novel Long-Acting Granulocyte Colony Stimulating Factor (GCSF) to Treat Chemotherapy-induced Neutropenia
26-May-14 03:31PM  Spectrum - Pullback An Opportunity To Jump In at Seeking Alpha
03:31PM  Spectrum - Pullback An Opportunity To Jump In
20-May-14 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials EDGAR Online Financials
01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
15-May-14 02:14PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Spectrum Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty PR Newswire
02:14PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Spectrum Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty
14-May-14 11:57AM  Spectrum mentioned as potential takeover target by Forbes contributor at theflyonthewall.com
11:57AM  Spectrum mentioned as potential takeover target by Forbes contributor
11:48AM  Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play at Forbes
11:48AM  Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
12-May-14 08:40AM  Dendreon Falls on Q1 Loss Zacks
08:00AM  Spectrum Pharma Up on Q1 Earnings Zacks
08:00AM  Spectrum Pharma Up on Q1 Earnings
07:06AM  PharmAthene (PIP) Catches Eye: Stock Rises 6.4% Zacks
07:06AM  PharmAthene (PIP) Catches Eye: Stock Rises 6.4%
06:03AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09-May-14 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on May 13th Business Wire +9.77%
08-May-14 07:40PM  Spectrum Pharmaceuticals' (SPPI) CEO Rajesh Shrotriya on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:40PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  Spectrum Pharmaceuticals (SPPI) Q1 2014 Results - Earnings Call Webcast at Seeking Alpha
04:04PM  Spectrum reports Q1 adjusted EPS 1c, may not compare to consensus (22c) at theflyonthewall.com
04:00PM  Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2014 Business Wire
07:07AM  Q1 2014 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
07-May-14 08:20AM  Is A Short Squeeze Ahead for Spectrum Pharmaceuticals (SPPI)? Zacks
02-May-14 09:32AM  Clinical Winners and Losers: Spectrum Pharmaceuticals and Cytokinetics at Motley Fool
01-May-14 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2014 Financial Results Teleconference and Webcast Business Wire
24-Apr-14 04:50PM  Spectrum Pharma Candidate Gets Positive Data Zacks
23-Apr-14 11:58AM  Spectrum Pharma to seek cancer drug approval in 3rd qtr Reuters
07:26AM  Spectrum Pharma's cancer drug meets main goal in trial Reuters
07:13AM  Ligand's partner Spectrum says Captisol-enabled melphalan meets primary endpoint theflyonthewall.com
07:00AM  Spectrum Pharmaceuticals Pivotal Trial of Captisol-Enabled (Propylene Glycol-Free) Melphalan Meets Primary Endpoint Business Wire
21-Apr-14 07:00AM  Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer Business Wire
17-Apr-14 05:03PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online
11-Apr-14 07:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin EDGAR Online -5.17%
10-Apr-14 07:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant EDGAR Online -7.13%
08-Apr-14 04:04PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Spectrum Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty Business Wire
01:13PM  Is biotech caught in a bubble, and is it popping? at MarketWatch
31-Mar-14 04:59PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
21-Mar-14 04:32PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements EDGAR Online
18-Mar-14 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials EDGAR Online Financials
12-Mar-14 06:11AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
07-Mar-14 10:02AM  Analysis Of The Near-Term Value Drivers Of Spectrum Pharmaceuticals at Seeking Alpha
10:02AM  Analysis Of The Near-Term Value Drivers Of Spectrum Pharmaceuticals
09:00AM  Spectrum Pharma Posts Lower Y/Y Q4 Earnings Zacks
09:00AM  Spectrum Pharma Posts Lower Y/Y Q4 Earnings
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th Business Wire
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th
06-Mar-14 09:10PM  Spectrum Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:10PM  Spectrum Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript
04:53PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  Spectrum Pharmaceuticals, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
04:25PM  Spectrum Pharmaceuticals, Inc. Discusses Q4 2013 Results (Webcast)
04:00PM  Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results Business Wire
04:00PM  Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company's commercialized drug products include FUSILEV for the treatment of patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma; ZEVALIN injection for intravenous use as a prescription medication; and MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for the treatment of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. It also develops BELEODAQ for the treatment of various hematological and solid tumors; Captisol-enabled MELPHALAN, an intravenous formulation of MELPHALAN for clinicians and patients in the multiple myeloma transplant setting; APAZIQUONE to treat non-muscle invasive bladder cancer; and SPI-2012 for the treatment of chemotherapy-induced neutropenia. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe and Japan. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAIDA ANTHONY E IIIDirectorJul 09Option Exercise6.0520,000121,00044,907Jul 11 01:02 PM
SHROTRIYA RAJESH C MDChairman, CEO & PresidentSep 04Option Exercise3.41403,9481,378,5821,861,228Sep 05 08:53 PM